A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Clinical trial NCT06256484 · TERMINATED
Trial details
- NCT number
- NCT06256484
- Sponsor
- Atara Biotherapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-06
- Primary completion
- 2025-03-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.